Ji Zhao-Chen, Lin Shan-Shan, Hu Hai-Yin, Sheng Xiao-di, Yang Feng-Wen, Wang Xian-Liang
Center for Evidence-based Medicine,Tianjin University of Traditional Chinese Medicine Tianjin 301617,China.
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin 300381,China National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion Tianjin 300381,China.
Zhongguo Zhong Yao Za Zhi. 2022 Apr;47(7):1955-1988. doi: 10.19540/j.cnki.cjcmm.20211223.501.
This study aims to systematically evaluate the effect of oral Chinese patent medicines on hypertension with network Meta-analysis. Randomized controlled trials on the treatment of hypertension with oral Chinese patent medicine combined with conventional western medicine were retrieved from China National Knowledge Infrastructure(CNKI), Wanfang, VIP, SinoMed, PubMed, EMbase, and Cochrane Library(from establishment of the database to August 2021). Two researchers independently screened the articles, extracted the data, and evaluated article quality. Then R 4.1.0 was employed for data analysis. Finally, 195 eligible articles were screened out, involving 22 546 patients and 18 oral Chinese patent medicines. The results of the network Meta-analysis are as follows. In terms of reducing systolic blood pressure(SBP) and diastolic blood pressure(DBP), Xuesaitong, Qiangli Dingxuan Tablets, Songling Xuemaikang Capsules combined with conventional western medicine are superior. In improving blood lipids, the overall effects of Xinmaitong Capsules, Compound Xueshuantong Capsules, Ginkgo Folium preparations, Yindan Xinnaotong Soft Capsules, and Naoxintong Capsules combined with conventional western medicine are outstanding. In terms of regulating endothelial function, Yindan Xinnaotong Soft Capsules, Xinmaitong Capsules, Zhenju Jiangya Tablets, Compound Danshen Dripping Pills, Xuesaitong with conventional western medicine have certain advantages. As for the safety, the incidence of adverse reactions of conventional western medicine combined with oral Chinese patent medicines is lower than that of conventional western medicine alone. In summary, compared with conventional western medicine alone, the 18 oral Chinese patent medicines combined with conventional western medicine in the treatment of hypertension show advantages in improving blood pressure, blood lipids, and endothelial function. Among them, Xuesaitong, Qiangli Dingxuan Tablets, and Songling Xuemaikang Capsules may be the best oral Chinese patent medicines for lowering blood pressure. The conclusion needs to be further verified by more high-quality studies.
本研究旨在通过网状Meta分析系统评价口服中成药治疗高血压的效果。从中国知网(CNKI)、万方、维普、中国生物医学文献数据库、PubMed、EMbase以及考克兰图书馆(从数据库建立至2021年8月)检索口服中成药联合传统西药治疗高血压的随机对照试验。两名研究人员独立筛选文章、提取数据并评估文章质量。然后采用R 4.1.0进行数据分析。最终筛选出195篇合格文章,涉及22546例患者和18种口服中成药。网状Meta分析结果如下。在降低收缩压(SBP)和舒张压(DBP)方面,血塞通、强力定眩片、松龄血脉康胶囊联合传统西药效果更佳。在改善血脂方面,心脉通胶囊、复方血栓通胶囊、银杏叶制剂、银丹心脑通软胶囊、脑心通胶囊联合传统西药的总体效果突出。在调节内皮功能方面,银丹心脑通软胶囊、心脉通胶囊、珍菊降压片、复方丹参滴丸、血塞通联合传统西药具有一定优势。至于安全性,传统西药联合口服中成药的不良反应发生率低于单纯使用传统西药。综上所述,与单纯使用传统西药相比,18种口服中成药联合传统西药治疗高血压在改善血压、血脂和内皮功能方面具有优势。其中,血塞通、强力定眩片和松龄血脉康胶囊可能是降血压效果最佳的口服中成药。该结论需要更多高质量研究进一步验证。